Clinic
Guam Healthcare Development Incorporated
Guam Healthcare Development Incorporated was paid $30.86M by Medicaid between Jul 2019 and Nov 2024, across 112 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoGUAM HEALTHCARE DEVELOPMENT INCORPORATED
DEDEDO, GU 96929
DEDEDO, GU 96929
33aNPI1326447939assigned 08/19/2014
33bProvider typeClinic/Center
28Total paid$30.86M
24GClaims152,454
24DCodes billed112
24AFirst – last monthJul 2019 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 4,020 | $740K | |
| 2020 | 10,516 | $1.52M | |
| 2021 | 16,278 | $2.95M | |
| 2022 | 42,578 | $8.42M | |
| 2023 | 53,753 | $11.22M | |
| 2024incomplete | 25,309 | $6.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 14,494 | 11,727 | $9.56M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 13,921 | 11,285 | $5.77M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 8,596 | 6,635 | $3.70M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.5% | 11,222 | 9,396 | $2.61M |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 6,377 | 5,587 | $704K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 3,703 | 3,428 | $693K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.2% | 11,423 | 3,233 | $678K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 1,806 | 1,720 | $674K |
| 80053 | Comprehensive metabolic panel | 1.8% | 3,584 | 3,197 | $565K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 9,382 | 8,096 | $452K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.4% | 5,003 | 1,378 | $439K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 883 | 653 | $425K |
100 more codes
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 465 | $341K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 12,732 | $324K |
| 84484 | <1% | 1,782 | $272K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,011 | $253K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 559 | $239K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,529 | $230K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,517 | $218K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 924 | $166K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 392 | $138K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 279 | $133K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,200 | $128K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,677 | $126K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 659 | $123K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 843 | $120K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 877 | $120K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,342 | $117K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 658 | $99K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,778 | $94K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 884 | $94K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 268 | $85K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,125 | $82K |
| 81001 | <1% | 3,292 | $61K | |
| 94010 | <1% | 189 | $61K | |
| 83605 | <1% | 697 | $59K | |
| 82803 | <1% | 478 | $59K | |
| 85396 | <1% | 700 | $55K | |
| 80076 | <1% | 2,210 | $52K | |
| 87400 | <1% | 966 | $48K | |
| 85027 | <1% | 1,267 | $45K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 103 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 861 | $43K |
| 83690 | <1% | 605 | $42K | |
| 82728 | <1% | 188 | $39K | |
| 83880 | <1% | 178 | $38K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,898 | $38K |
| 99221 | <1% | 392 | $31K | |
| 80061 | Lipid panel | <1% | 257 | $29K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 765 | $29K |
| 83021 | <1% | 477 | $28K | |
| 83735 | <1% | 478 | $26K | |
| 82330 | <1% | 478 | $21K | |
| 83020 | <1% | 477 | $20K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 302 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 192 | $17K |
| 94729 | <1% | 172 | $14K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,298 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 52 | $12K |
| 94726 | <1% | 50 | $12K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 386 | $12K |
| 81025 | <1% | 111 | $10K | |
| 73630 | <1% | 87 | $8K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 222 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 98 | $7K |
| 87340 | <1% | 57 | $6K | |
| 94642 | <1% | 33 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 81 | $6K |
| 94760 | <1% | 171 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 76 | $5K |
| 83540 | <1% | 63 | $4K | |
| 85610 | <1% | 91 | $4K | |
| 86140 | <1% | 85 | $3K | |
| 84702 | <1% | 13 | $3K | |
| 82310 | <1% | 60 | $3K | |
| 80051 | <1% | 476 | $3K | |
| 86803 | <1% | 12 | $3K | |
| 11720 | <1% | 23 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 53 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 24 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 25 | $2K |
| 82962 | <1% | 250 | $2K | |
| 88304 | <1% | 163 | $2K | |
| 86704 | <1% | 12 | $2K | |
| 82607 | <1% | 13 | $2K | |
| 86706 | <1% | 12 | $2K | |
| 0002A | <1% | 16 | $1K | |
| 84439 | <1% | 30 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 25 | $1K |
| 88307 | <1% | 14 | $1K | |
| 82746 | <1% | 14 | $1K | |
| 0001A | <1% | 14 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 58 | $1K |
| 94375 | <1% | 85 | $1K | |
| 82150 | <1% | 15 | $999.96 | |
| 70496 | <1% | 14 | $839.40 | |
| 70498 | <1% | 14 | $839.40 | |
| 83615 | <1% | 16 | $777.28 | |
| 95012 | <1% | 16 | $727.24 | |
| 76775 | <1% | 29 | $551.39 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 112 | $444.00 |
| 85045 | <1% | 12 | $426.91 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $333.34 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 23 | $260.00 |
| 93248 | <1% | 12 | $196.00 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 197 | $194.00 |
| 93971 | <1% | 12 | $188.01 | |
| 99152 | <1% | 15 | $133.54 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 26 | $42.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 24 | $30.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 22 | $24.00 |
| 91301 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWIELAARD, ALEXANDER (CHIEF EXECUTIVE OFFICER)